18/02/2026
More than 600 ADCs are currently in development worldwide — and timelines are accelerating.
As programs move faster, the need for integrated, reliable ADC manufacturing has never been greater.
Our latest investment at Le Mans 🇫🇷 strengthens our ability to support complex ADC programs with greater control, speed and predictability — from early development to commercial supply.
We’re proud to contribute to the supply chain of 6 of the 14 FDA-approved ADCs on the market today — and we continue to invest where it matters most.
🔗 Full announcement — link in bio.